Archer C, Randhawa M, Kim H, et al. Real world data on intensive follow-up for stage IV metastatic melanoma patients receiving ipilimumab and nivolumab: a safer model of care? SMR 2017, abstract P07-1.
Alectinib versus crizotinib bij ALK-positief NSCLC
jun 2017 | Longoncologie